Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

 

Recent papers

    ( Database Archives )

Table of Content

2018_06 Genes PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide)
2018_06 Leukaemias t(11;12)(p15;q13) NUP98/HOXC11
2018_06 Leukaemias t(7;14)(q35;q32.1) TRB/TCL1A
2018_06 Genes FZD5 (frizzled class receptor 5)
2018_06 Leukaemias t(14;16)(q32;q23) IGH/MAF
2018_06 Leukaemias i(5)(p10) in hematological malignancies
2018_06 Leukaemias Follicular dendritic cell in lymphomas of follicular origin
2018_06 Leukaemias Chronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)
2018_05 Genes POLE (DNA polymerase epsilon, catalytic subunit)
2018_05 Genes POLD1 (DNA polymerase delta 1, catalytic subunit)
2018_05 Leukaemias t(6;8)(p21;q24) MYC/SUPT3H
2018_05 Leukaemias der(3)t(3;3)(p25-26;q12-21)
2018_05 Leukaemias i(9)(p10)
2018_04 Genes NRIP1 (nuclear receptor interacting protein 1)
2018_04 Genes XRCC2 (X-ray repair cross complementing 2)
2018_04 Genes PALB2 (partner and localizer of BRCA2)
2018_04 Leukaemias t(11;19)(q23;p13) KMT2A/MYO1F
2018_04 Leukaemias t(11;17)(q23;q21) KMT2A/ACACA
2018_04 Leukaemias -20 or monosomy 20
2018_04 Leukaemias TBL1XR1/MECOM fusion
2018_04 Case Reports Acute myeloid leukemia with t(12;13)(p13;q12) and ETV6 involvement; Case report and review of literature
2018_04 Case Reports A first case of adult secondary acute myeloid leukemia with the recurrent KMT2A-GAS7 fusion
2018_03 Solid Tumors Bone: Osteochondroma
2018_03 Solid Tumors Bone: Enchondroma
2018_03 Genes PNP (Purine Nucleoside Phosphorylase)
2018_03 Leukaemias der(17)t(17;17)(p13;q12-21)
2018_03 Leukaemias der(Y)t(Y;1)(q11-12;q12-21)
2018_03 Leukaemias der(2)t(1;2)(q12-21;q37)
2018_03 Leukaemias i(22)(q10) in myeloid malignancies
2018_03 Leukaemias Acute Lymphoblastic Leukemia with Hypereosinophilia
2018_03 Case Reports t(4;11)(q23;p15) in paediatric early T cell precursor acute lymphoblastic leukemia.
2018_02 Leukaemias t(9;22)(p24;q11.2) BCR/JAK2
2018_02 Genes NCOA1 (Nuclear receptor coactivator 1)
2018_02 Genes MAD1L1 (mitotic arrest deficient 1 like 1)
2018_02 Genes LIPE (lipase E, hormone sensitive type)
2018_02 Deep Insights Does DNA ploidy and synthesis phase dynamic accentuate the predictive power of oestrogen and progesterone receptors in breast cancer progression and prognosis?
2018_02 Leukaemias dic(7;12)(p10-p12;p11-p13)
2018_02 Leukaemias Nodal marginal zone lymphoma (NMZL)
2018_01 Leukaemias t(1;11)(q24;p15) NUP98/PRRX1
2018_01 Leukaemias Burkitt's lymphoma (BL)
2018_01 Leukaemias t(6;17)(p21;p13)
2018_01 Leukaemias der(4)t(1;4)(q11-32;q34-35)
2018_01 Leukaemias der(20)t(1;20)(q12-21;p13) in hematological malignances
2018_01 Leukaemias Plasmacytoma (Solitary bone plasmacytoma, extramedullary plasmacytoma)
2018_01 Case Reports t(6;17)(p21;p13) associated with t(3;3)(q21;q26.2) in AML
2018_01 Case Reports t(6;17)(p21;p13) and acquisition of the Philadelphia chromosome translocation with p190 BCR-ABL1 transcript during the course of myelodysplastic syndrome
2017_12 Genes BCL2 (B-Cell Leukemia/Lymphoma 2)
2017_12 Leukaemias Mantle cell lymphoma
2017_12 Genes CDK2 (cyclin dependent kinase 2)
2017_12 Leukaemias t(X;14)(p22;q32) or t(Y;14)(p11;q32) IGH/CRLF2
2017_12 Leukaemias t(2;11)(p21;q24) MIR125B1/?
2017_11 Solid Tumors Bone: Chordoma
2017_11 Solid Tumors Bone: Chondroblastoma
2017_11 Solid Tumors Bone: Giant cell tumour of bone
2017_11 Genes UHMK1 (U2AF homology motif kinase 1)
2017_11 Genes MAZ (MYC Associated Zinc Finger Protein)
2017_11 Genes FZD4 (frizzled class receptor 4)
2017_11 Genes CD2AP (CD2 associated protein)
2017_11 Leukaemias t(11;14)(q11;q32)
2017_11 Leukaemias t(7;14)(q34;q11) TRA/TRB
2017_11 Leukaemias t(3;11)(p11;p15) NUP98/POU1F1
2017_11 Leukaemias der(15)t(1;15)(q11-12;p11-13) and der(15)t(1;15)(q21-25;p10-13)
2017_11 Leukaemias Plasma Cell Neoplasms: an overview
2017_11 Case Reports A new case of adult Acute Myeloid Leukemia with t(3;3)(p24;q26)
2017_10 Leukaemias t(7;14)(p15;q11) TRD/HOXA10
2017_10 Genes NDC80 (NDC80, kinetochore complex component)
2017_10 Leukaemias t(7;14)(p15;q32)
2017_10 Leukaemias t(7;14)(p13;q11)
2017_10 Leukaemias der(21)t(1;21)(q11-12;p11-13) and der(21)t(1;21)(q21-32;p11-13)
2017_10 Leukaemias Pediatric T-Cell Acute Lymphoblastic Leukemia
2017_09 Cancer Prone Diseases Lynch Syndrome
2017_09 Genes YEATS4 (YEATS domain containing 4)
2017_09 Genes PCSK1 (proprotein convertase subtilisin/kexin type 1)
2017_09 Deep Insights Antibody-Drug Conjugates For the Treatment of Hematological Malignancy
2017_09 Leukaemias t(10;14)(q24;q32) NFKB2/IGH
2017_09 Leukaemias t(2;18)(p11;q21)IGK/BCL2 and IGK/KDSR
2017_09 Leukaemias Follicular lymphomas of germinal center (B- or T-cell) origin
2017_09 Leukaemias Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL
2017_09 Leukaemias Primary cutaneous DLBCL, leg type
2017_09 Leukaemias Primary DLBCL of the central nervous system (CNS)
2017_09 Leukaemias DLBCL subtype: Extranodal lymphoma
2017_08 Genes MYC (MYC proto-oncogene, bHLH transcription factor)
2017_08 Genes BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase))
2017_08 Leukaemias t(10;14)(q24;q11) TLX1/TRD
2017_08 Solid Tumors Malignant Mesothelioma
2017_08 Genes SNW1 (SNW domain containing 1)
2017_08 Genes HDAC1 (histone deacetylase 1)
2017_08 Genes GRHL2 (grainyhead like transcription factor 2)
2017_08 Leukaemias i(7)(q10) in myeloid malignancies
2017_08 Leukaemias Myelodysplastic/myeloproliferative neoplasms
2017_07 Leukaemias t(6;11)(q27;q23) KMT2A/AFDN
2017_07 Cancer Prone Diseases Down syndrome
2017_07 Genes IDH2 (isocitrate dehydrogenase 2 (NADP+), mitochondrial)
2017_07 Leukaemias +X solely in lymphomas
2017_07 Leukaemias +X solely in myeloid malignancies
2017_07 Leukaemias +X solely in ALL
2017_06 Genes ALCAM (Activated Leukocyte Cell Adhesion Molecule)
2017_06 Deep Insights LINE-1-encoded Reverse Transcriptase in the genesis and therapy of cancer
2017_06 Leukaemias t(18;21)(p11;q11)
2017_06 Leukaemias i(8)(q10) in ALL
2017_06 Leukaemias del(7)(p11-15) solely
2017_06 Leukaemias Subcutaneous panniculitis-like T-cell lymphoma
2017_06 Leukaemias Myelodysplastic syndrome with excess blasts
2017_06 Leukaemias Acute lymphoblastic leukemia in Down syndrome
2017_06 Leukaemias Florid follicular hyperplasia PTLD
2017_06 Case Reports Isolated 1q21 rearrangement der(20)t(1;20)(q21;p13) with telomere involvement of 20p in a case of longstanding myelodysplastic syndrome
2017_05 Genes C2orf3
2017_05 Leukaemias t(1;8)(p21-22;q24)
2017_05 Leukaemias dup(1q) in ALL
2017_05 Leukaemias del(1p) solely
2017_05 Leukaemias Mixed phenotype acute leukemia (MPAL)
2017_05 Leukaemias Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2017_04 Solid Tumors Kidney: Renal Oncocytoma
2017_04 Leukaemias M3/M3v acute myeloid leukemia (AML M3/M3v)
2017_04 Leukaemias Castleman's disease
2017_04 Genes WDR48 (WD repeat domain 48)
2017_04 Genes PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha)
2017_04 Genes INPP4B (Inositol Polyphosphate-4-Phosphate Type II B)
2017_04 Leukaemias t(6;11)(q24.1;p15.5) NUP98/CCDC28A
2017_04 Leukaemias t(4;9)(q21.22;p24) SEC31A/JAK2
2017_04 Leukaemias t(1;8)(p11-13;q24)
2017_04 Leukaemias t(1;5)(p32;q31) without TAL1 rearrangement
2017_04 Leukaemias Polymorphic PTLD
2017_04 Leukaemias Myeloid/Lymphoid neoplasms with abnormalities of PDGFRB
2017_04 Leukaemias Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA
2017_04 Leukaemias Monomorphic PTLD (B- and T/NK-cell types)
2017_04 Leukaemias Double Hit Lymphoma (DHL)
2017_04 Leukaemias Classical Hodgkin lymphoma type PTLD
2017_03 Solid Tumors Soft Tissues: Extraskeletal myxoid chondrosarcoma
2017_03 Genes MAPK6 (mitogen-activated protein kinase 6)
2017_03 Genes MAPK4 (mitogen-activated protein kinase 4)
2017_03 Genes CEBPE (CCAAT/enhancer binding protein epsilon)
2017_03 Leukaemias t(14;19)(q32;p13) IGH/EPOR
2017_03 Leukaemias t(11;11)(q14;q23) KMT2A/PICALM
2017_03 Leukaemias t(X;11)(q28;p15) NUP98/HMGB3
2017_03 Leukaemias t(5;11)(q33;q13) NUMA1/PDGFRB a novel fusion
2017_03 Leukaemias t(3;17)(q26;q12-21) TBL1XR1/RARA
2017_03 Leukaemias t(2;17)(q32;q21) NABP1/RARA
2017_03 Leukaemias t(1;17)(p34;q21) IRF2BP2/RARA
2017_03 Leukaemias del(X)(p22p22) P2RY8/CRLF2
2017_03 Leukaemias Myeloid proliferations in Down syndrome
2017_02 Leukaemias t(4;11)(q21;q23) KMT2A/AFF1
2017_02 Solid Tumors Kidney: ALK-rearranged renal cell carcinoma
2017_02 Genes WNT10B (wingless-type MMTV integration site family)
2017_02 Genes PGR (progesterone receptor)
2017_02 Leukaemias t(17;20)(q21;q11)
2017_02 Leukaemias r(8)
2017_02 Leukaemias inv(11)(p15q23) NUP98/KMT2A
2017_02 Leukaemias i(X)(q10) in male patients
2017_02 Leukaemias i(Xq10) in female patients
2017_02 Leukaemias del(18)(p11)
2017_02 Leukaemias Early T-cell precursor acute lymphoblastic leukemia
2017_01 Leukaemias t(5;17)(q35;q21) NPM1/RARA
2017_01 Leukaemias dic(9;12)(p13;p13) PAX5/ETV6
2017_01 Genes PIMREG (PICALM interacting mitotic regulator)
2017_01 Leukaemias t(5;17)(p11;q11)
2017_01 Leukaemias i(7)(q10)
2017_01 Leukaemias del(6q)
2017_01 Leukaemias Multiple Myeloma
2017_01 Leukaemias Aggressive natural killer leukemia (ANKL)
2017_01 Leukaemias Acute myeloid leukemia with myelodysplasia related changes
2016_12 Solid Tumors t(2;2)(p22;p22) LTBP1/BIRC6
2016_12 Solid Tumors Male breast cancer
2016_12 Genes SPARC (secreted protein acidic and cysteine-rich)
2016_12 Genes MIR150
2016_12 Genes ARHGAP21 (Rho GTPase activating protein 21)
2016_12 Leukaemias t(7;11)(p15;p15) NUP98/HOXA13
2016_12 Leukaemias t(5;17)(q35;q21) without RARA involvement in non-M3 AML
2016_12 Leukaemias t(5;14)(q35;q11) RANBP17 (or TLX3)/TRD
2016_12 Leukaemias t(2;2)(p22;p22) LTBP1/BIRC6
2016_12 Leukaemias i(X)(p10) in male patients
2016_12 Leukaemias i(X)(p10) in female patients
2016_12 Leukaemias dic(5;17)(q11-14;p11-13)
2016_12 Leukaemias Classification of Hodgkin lymphoma over years
2016_11 Solid Tumors Kidney: Papillary adenoma
2016_11 Solid Tumors Kidney: Metanephric adenoma
2016_11 Solid Tumors Kidney: Chromophobe renal cell carcinoma
2016_11 Solid Tumors Bone: Angiosarcoma
2016_11 Genes HLTF (helicase-like transcription factor)
2016_11 Genes PTPN9 (protein tyrosine phosphatase, non-receptor type 9)
2016_11 Leukaemias t(X;10)(p11;p12) DDX3X/MLLT10
2016_11 Leukaemias t(6;9)(p22;q34) DEK/NUP214 in Childhood
2016_11 Leukaemias i(18)(q10)
2016_11 Leukaemias dup (11q) in myeloid malignancies
2016_11 Leukaemias Mediastinal Gray Zone Lymphoma
2016_11 Leukaemias Follicular Dendritic Cell Sarcoma
2016_10 Cancer Prone Diseases Ataxia telangiectasia (A-T)
2016_10 Genes ATM (ataxia telangiectasia mutated)
2016_10 Genes KNL1 (cancer susceptibility candidate 5)
2016_10 Genes GSKIP (GSK3-beta interaction protein)
2016_10 Genes FMNL1 (formin like 1)
2016_10 Genes ATG2B (Autophagy-related 2B)
2016_10 Leukaemias del (5q) solely in Myelodysplastic syndrome
2016_10 Leukaemias del(13q) in chronic lymphocytic leukemia
2016_10 Leukaemias del(5)(q32q33) EBF1/PDGFRB
2016_10 Leukaemias Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
2016_09 Leukaemias t(1;9)(q24;q34) RCSD1/ABL1
2016_09 Leukaemias t(1;3)(p36;q21) PSMD2/PRDM16 ???
2016_09 Solid Tumors Nervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16
2016_09 Solid Tumors Breast: carcinoma with t(1;3)(p36;q13) PRDM16/BBX
2016_09 Genes KLK9 (kallikrein-related peptidase 9)
2016_09 Genes KLK14 (kallikrein-related peptidase 14
2016_09 Genes KLK13 (kallikrein-related peptidase 13)
2016_09 Genes KLK12 (kallikrein-related peptidase 12)
2016_09 Leukaemias der(X)t(X;8)(q28;q11.2)
2016_09 Leukaemias t(3;9)(p13;q34.1) FOXP1/ABL1
2016_09 Leukaemias t(1;22)(p36;q11) IGL/PRDM16
2016_09 Leukaemias t(1;17)(p36;q21) WNT3 or NSF/PRDM16
2016_09 Leukaemias t(1;3)(p36;q21) RPN1/PRDM16
2016_09 Leukaemias t(1;1)(p36;p36) PRDM16/SKI
2016_09 Leukaemias del(9p) in Acute Lymphoblastic Leukemia
2016_09 Leukaemias Primary mediastinal B-cell lymphoma (PMBL)
2016_08 Solid Tumors Kidney: Renal cell carcinoma with inv(X)(p11q12) NONO/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;17)(p11;q23) CLTC/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(6;11)(p21;q12) MALAT1/TFEB
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;17)(p11;q25) ASPSCR1/TFE3
2016_08 Leukaemias t(7;12)(q36;p13) MNX1/ETV6
2016_08 Leukaemias t(2;11)(p21;q23) KMT2A/?
2016_08 Solid Tumors Kidney: Renal cell carcinomas with MiT family translocation
2016_08 Genes PDCD10 (Programmed cell death 10)
2016_08 Genes DOT1L (DOT1 like histone H3K79 methyltransferase)
2016_08 Genes CALR (calreticulin)
2016_08 Leukaemias t(2;11)(p21;q23) without KMT2A (MLL) rearrangement
2016_08 Leukaemias t(1;12)(p36;p13) ETV6/PRDM16
2016_08 Leukaemias t(1;7)(p36;p12) IKZF1/PRDM16
2016_08 Leukaemias T-cell/histiocyte rich large B-cell lymphoma
2016_08 Leukaemias In situ follicular neoplasia
2016_08 Case Reports Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 11 16:42:12 CEST 2018

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA